Home › All Companies › ANGO › Quarterly Report

ANGIODYNAMICS INC (ANGO) — Quarterly Report

AI-Powered SEC Filing Analysis

← All ANGO filings
Latest Quarterly Report Filed: 2026-01-06

Key Insights

  • The company reported a decline in revenue across both its MedTech and MedDevice segments for the quarter ended November 30, 2025 compared to the prior year period, indicating potential challenges in the business.
  • Gross margins remained stable during the quarter, suggesting the company was able to maintain its profitability despite the revenue decline.
  • The company renewed its revolving credit facility, providing additional financial flexibility to fund operations and future growth initiatives.
Sentiment: Neutral Significance: 6/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-01-06. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for ANGIODYNAMICS INC

Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.